Abstract
Gastrointestinal neuroendocrine tumors (GI-NETs) arise from diffuse neuroendocrine system cells, which express neuroendocrine markers, produce certain peptide or amine hormones, and contain dense core secretory granules. NETs still retain these features after the transformation of normal neuroendocrine cells.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Dayal Y. The neuroendocrine cell system of the gut and pancreas: introduction and historical perspectives. In: Dayal Y, ed. CRC Press; 1991:1–32.
DeLellis RA: The neuroendocrine system and its tumors: an overview, Am J Clin Pathol. 2001; 115 suppl:S5-S16.
Soga J, Tazawa K. Pathologic analysis of carcinoids. Histologic reevaluation of 62 cases. Cancer. 1971;28:990–998.
Smith DM Jr, Haggitt RC. A comparative study of generic stains for carcinoid secretory granules. Am J Surg Pathol. 1983;7:61–68.
Fahrenkamp AG, Wibbeke C, Winde G, et al. Immunohistochemical distribution of chromogranins A and B and secretogranin II in neuroendocrine tumours of the gastrointestinal tract. Virchows Arch. 1995;426:361–367.
Taupenot L, Harper KL, O’Connor DT. The chromogranin-secretogranin family [see comment]. N Engl J Med. 2003;348:1134–1149.
Wiedenmann B, Franke WW, Kuhn C, Moll R, Gould VE. Synaptophysin: a marker protein for neuroendocrine cells and neoplasms. Proc Natl Acad Sci USA. 1986;83:3500–3504.
Rode J, Dhillon AP, Doran JF, Jackson P, Thompson RJ. PGP 9.5, a new marker for human neuroendocrine tumours. Histopathology. 1985;9:147–158.
Schmechel D, Marangos PJ, Brightman M. Neurone-specific enolase is a molecular marker for peripheral and central neuroendocrine cells. Nature. 1978;276:834–836.
Williams ED, Sandler M. The classification of carcinoid tumours. Lancet. 1963;1:238–239.
van Bogaert LJ. The diffuse endocrine system and derived tumours. Histological and histochemical characteristics. Acta Histochem. 1982;70:122–129.
Jaffee IM, Rahmani M, Singhal MG, Younes M. Expression of the intestinal transcription factor CDX2 in carcinoid tumors is a marker of midgut origin. Arch Pathol Lab Med. 2006;130:1522–1526.
Rindi G, Leiter AB, Kopin AS, Bordi C, Solcia E. The “normal” endocrine cell of the gut: changing concepts and new evidences. Ann N Y Acad Sci. 2004;1014:1–12.
DeLellis RA, Dayal Y, Wolfe HJ. Carcinoid tumors. Changing concepts and new perspectives. Am J Surg Pathol. 1984;8:295–300.
Solcia E, Kloppel G, Sobin LH. Endocrine tumors of the gastrointestinal tract. In: Solcia E, Kloppel G, Sobin LH, eds. New York: Springer-Verlag; 2000:61–68.
Kloppel G, Perren A, Heitz PU. The gastroenteropancreatic neuroendocrine cell system and its tumors: the WHO classification. Ann N Y Acad Sci. 2004;1014:13–27.
Rindi G, Kloppel G, Alhman H, et al. TNM staging of foregut (neuro)endocrine tumors: a consensus proposal including a grading system. Virchows Arch. 2006;449:395–401.
Rindi G, Kloppel G, Couvelard A, et al. TNM staging of midgut and hindgut (neuro) endocrine tumors: a consensus proposal including a grading system. Virchows Arch. 2007;451:757–762.
Modlin IM, Lye KD, Kidd M. A 5-decade analysis of 13,715 carcinoid tumors. Cancer. 2003;97:934–959.
Rindi G, Villanacci V, Ubiali A. Biological and molecular aspects of gastroenteropancreatic neuroendocrine tumors. Digestion. 2000;62(suppl 1):19–26.
Chandrasekharappa SC, Guru SC, Manickam P, et al. Positional cloning of the gene for multiple endocrine neoplasia-type 1. Science. 1997;276:404–407.
Bordi C, Corleto VD, Azzoni C, et al. The antral mucosa as a new site for endocrine tumors in multiple endocrine neoplasia type 1 and Zollinger-Ellison syndromes. J Clin Endocrinol Metab. 2001;86:2236–2242.
Pipeleers-Marichal M, Somers G, Willems G, et al. Gastrinomas in the duodenums of patients with multiple endocrine neoplasia type 1 and the Zollinger-Ellison syndrome [see comment]. N Engl J Med. 1990;322:723–727.
Klein A, Clemens J, Cameron J. Periampullary neoplasms in von Recklinghausen’s disease. Surgery. 1989;106:815–819.
Kheir SM, Halpern NB. Paraganglioma of the duodenum in association with congenital neurofibromatosis. Possible relationship. Cancer. 1984;53:2491–2496.
Lollgen RM, Hessman O, Szabo E, Westin G, Akerstrom G. Chromosome 18 deletions are common events in classical midgut carcinoid tumors. Int J Cancer. 2001;92:812–815.
D’Adda T, Candidus S, Denk H, Bordi C, Hofler H. Gastric neuroendocrine neoplasms: tumour clonality and malignancy-associated large X-chromosomal deletions. J Pathol. 1999;189:394–401.
Higham AD, Bishop LA, Dimaline R, et al. Mutations of RegIalpha are associated with enterochromaffin-like cell tumor development in patients with hypergastrinemia [see comment]. Gastroenterology. 1999;116:1310–1318.
Modlin IM, Sandor A. An analysis of 8305 cases of carcinoid tumors. Cancer. 1997;79:813–829.
Hoang MP, Hobbs CM, Sobin LH, Albores-Saavedra J. Carcinoid tumor of the esophagus: a clinicopathologic study of four cases. Am J Surg Pathol. 2002;26:517–522.
Ready AR, Soul JO, Newman J, Matthews HR. Malignant carcinoid tumour of the oesophagus [see comment]. Thorax. 1989;44:594–596.
Voillemot N, Potet F, Mary JY, Lewin MJ. Gastrin cell distribution in normal human stomachs and in patients with Zollinger-Ellison syndrome. Gastroenterology. 1978;75:61–65.
Modlin IM, Nangia AK. The pathobiology of the human enterochromaffin-like cell. Yale J Biol Med. 1992;65:775-792. discussion 827–779.
Freston JW, Borch K, Brand SJ, et al. Effects of hypochlorhydria and hypergastrinemia on structure and function of gastrointestinal cells. A review and analysis. Dig Dis Sci. 1995;40:50S-62S.
McCloy RF, Arnold R, Bardhan KD, et al. Pathophysiological effects of long-term acid suppression in man. Dig Dis Sci. 1995;40:96S-120S.
Rindi G, Luinetti O, Cornaggia M, Capella C, Solcia E. Three subtypes of gastric argyrophil carcinoid and the gastric neuroendocrine carcinoma: a clinicopathologic study [see comment]. Gastroenterology. 1993;104:994–1006.
Solcia E, Rindi G, Fiocca R, et al. Distinct patterns of chronic gastritis associated with carcinoid and cancer and their role in tumorigenesis. Yale J Biol Med. 1992;65:793-804. discussion 827–799.
Richards AT, Hinder RA, Harrison AC. Gastric carcinoid tumours associated with hypergastrinaemia and pernicious anaemia - regression of tumors by antrectomy. A case report. S Afr Med J. 1987;72:51–53.
Maury CP, Tornroth T, Teppo AM. Atrophic gastritis in Sjogren’s syndrome. Morphologic, biochemical, and immunologic findings. Arthritis Rheum. 1985;28:388–394.
D’Adda T, Keller G, Bordi C, Hofler H. Loss of heterozygosity in 11q13-14 regions in gastric neuroendocrine tumors not associated with multiple endocrine neoplasia type 1 syndrome. Lab Invest. 1999;79:671–677.
Azzoni C, Doglioni C, Viale G, et al. Involvement of BCL-2 oncoprotein in the development of enterochromaffin-like cell gastric carcinoids. Am J Surg Pathol. 1996;20:433–441.
Solcia E, Capella C, Fiocca R, Rindi G, Rosai J. Gastric argyrophil carcinoidosis in patients with Zollinger-Ellison syndrome due to type 1 multiple endocrine neoplasia. A newly recognized association. Am J Surg Pathol. 1990;14:503–513.
Bordi C, D’Adda T, Azzoni C, Ferraro G. Pathogenesis of ECL cell tumors in humans. Yale J Biol Med. 1998;71:273–284.
Cadiot G, Lehy T, Mignon M. Gastric endocrine cell proliferation and fundic argyrophil carcinoid tumors in patients with the Zollinger-Ellison syndrome. Acta Oncol. 1993;32:135–140.
Richards ML, Gauger P, Thompson NW, Giordano TJ. Regression of type II gastric carcinoids in multiple endocrine neoplasia type 1 patients with Zollinger-Ellison syndrome after surgical excision of all gastrinomas. World J Surg. 2004;28:652–658.
Borch K, Ahren B, Ahlman H, Falkmer S, Granerus G, Grimelius L. Gastric carcinoids: biologic behavior and prognosis after differentiated treatment in relation to type. Ann Surg. 2005;242:64–73.
Rindi G, Solcia E. Endocrine hyperplasia and dysplasia in the pathogenesis of gastrointestinal and pancreatic endocrine tumors. Gastroenterol Clin North Am. 2007;36:851–865.
Solcia E, Bordi C, Creutzfeldt W, et al. Histopathological classification of nonantral gastric endocrine growths in man. Digestion. 1988;41:185–200.
Solcia E, Fiocca R, Rindi G, Villani L, Cornaggia M, Capella C. The pathology of the gastrointestinal endocrine system. Endocrinol Metab Clin North Am. 1993;22:795–821.
Solcia E, Fiocca R, Villani L, Luinetti O, Capella C. Hyperplastic, dysplastic, and neoplastic enterochromaffin-like-cell proliferations of the gastric mucosa. Classification and histogenesis. Am J Surg Pathol. 1995;19(suppl 1):S1-S7.
Capella C SE, Sobin LH, Arnold R, Endocrine tumors of the small intestine. In: Hamilton SR AL, ed. Lyon: IARC Press; 2000:77–82.
Donow C, Pipeleers-Marichal M, Schroder S, Stamm B, Heitz PU, Kloppel G. Surgical pathology of gastrinoma. Site, size, multicentricity, association with multiple endocrine neoplasia type 1, and malignancy. Cancer. 1991;68:1329–1334.
Thom AK, Norton JA, Axiotis CA, Jensen RT. Location, incidence, and malignant potential of duodenal gastrinomas. Surgery. 1991;110:1086-1091. discussion 1091–1083.
Merchant SH, VanderJagt T, Lathrop S, Amin MB. Sporadic duodenal bulb gastrin-cell tumors: association with Helicobacter pylori gastritis and long-term use of proton pump inhibitors. Am J Surg Pathol. 2006;30:1581–1587.
Dayal Y, Doos WG, O’Brien MJ, Nunnemacher G, DeLellis RA, Wolfe HJ. Psammomatous somatostatinomas of the duodenum. Am J Surg Pathol. 1983;7:653–665.
Dayal Y, Tallberg KA, Nunnemacher G, DeLellis RA, Wolfe HJ. Duodenal carcinoids in patients with and without neurofibromatosis. A comparative study. Am J Surg Pathol. 1986;10:348–357.
Fendrich V, Ramaswamy A, Slater EP, Bartsch DK. Duodenal somatostatinoma associated with Von Recklinghausen’s disease. J Hepatobiliary Pancreat Surg. 2004;11:417–421.
Karasawa Y, Sakaguchi M, Minami S, et al. Duodenal somatostatinoma and erythrocytosis in a patient with von Hippel-Lindau disease type 2A. Intern Med. 2001;40:38–43.
de Herder WW. Tumours of the midgut (jejunum, ileum and ascending colon, including carcinoid syndrome). Best Pract Res Clin Gastroenterol. 2005;19:705–715.
Bishop AE, Pietroletti R, Taat CW, Brummelkamp WH, Polak JM. Increased populations of endocrine cells in Crohn’s ileitis. Virchows Archiv A Pathol Anat Histopathol. 1987;410:391–396.
Burke AP, Sobin LH, Federspiel BH, Shekitka KM, Helwig EB. Goblet cell carcinoids and related tumors of the vermiform appendix. Am J Clin Pathol. 1990;94:27–35.
Anderson NH, Somerville JE, Johnston CF, Hayes DM, Buchanan KD, Sloan JM. Appendiceal goblet cell carcinoids: a clinicopathological and immunohistochemical study. Histopathology. 1991;18:61–65.
Stancu M, Wu T-T, Wallace C, Houlihan PS, Hamilton SR, Rashid A. Genetic alterations in goblet cell carcinoids of the vermiform appendix and comparison with gastrointestinal carcinoid tumors. Mod Pathol. 2003;16:1189–1198.
Kuroda N, Mizushima S, Guo L, et al. Goblet cell carcinoid of the appendix: investigation of the expression of beta-catenin and E-cadherin. Pathol Int. 2001;51:283–287.
Lin BT, Gown AM. Mixed carcinoid and adenocarcinoma of the appendix: report of 4 cases with immunohistochemical studies and a review of the literature. Appl Immunohistochem Mol Morphol. 2004;12:271–276.
Kortbeek J, Kelly JK, Preshaw RM. Carcinoid tumors and inflammatory bowel disease. J Surg Oncol. 1992;49:122–126.
Higaki S, Nishiaki M, Mitani N, Yanai H, Tada M, Okita K. Effectiveness of local endoscopic resection of rectal carcinoid tumors. Endoscopy. 1997;29:171–175.
Oberg K. Interferons in the management of neuroendocrine tumors and their possible mechanism of action. Yale J Biol Med. 1992;65:519-529. discussion 531–516.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2010 Springer Science+Business Media, LLC
About this chapter
Cite this chapter
Kuan, SF. (2010). Gastrointestinal Neuroendocrine Tumors. In: Hunt, J. (eds) Molecular Pathology of Endocrine Diseases. Molecular Pathology Library, vol 3. Springer, Boston, MA. https://doi.org/10.1007/978-1-4419-1707-2_24
Download citation
DOI: https://doi.org/10.1007/978-1-4419-1707-2_24
Published:
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4419-1706-5
Online ISBN: 978-1-4419-1707-2
eBook Packages: MedicineMedicine (R0)